Technology and Innovation

Meeting the Moment: Addressing Barriers and Facilitating Clinical Adoption of Artificial Intelligence in Medical Diagnosis

by Jenna Ogilvie | Sep 29, 2022 | Discussion Paper, Perspectives

  Introduction Clinical diagnosis is essentially a data curation and analysis activity through which clinicians seek to gather and synthesize enough pieces of information about a patient to determine their condition. The art and science of clinical diagnosis...

The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza

by Jenna Ogilvie | Sep 19, 2022 | Discussion Paper, Perspectives

    Since December 2019, much of the world’s focus has been on coronavirus disease 2019 (COVID-19) as it emerged from Wuhan, China and rapidly spread across the world. As of this writing, there were over 570 million confirmed cases of COVID-19 globally, and...

The Promise of Digital Health: Then, Now, and the Future

by Jenna Ogilvie | Jun 27, 2022 | Discussion Paper, Perspectives

  Digital Health in the 21st Century Over the past several decades, the development and accelerated advancement of digital technology has prompted change across virtually all aspects of human endeavor. The positive and negative effects of these changes have been...

Human Health and Equity in an Age of Robotics and Intelligent Machines

by Jenna Ogilvie | Mar 21, 2022 | Commentary, Perspectives

  Advances in robotic technologies and intelligent machines will transform the way clinicians care for members of our community within a variety of health care settings, including the home, and, perhaps of far greater importance, offer a means to create a much...

Health Product Manufacturers and Innovators COVID-19 Impact Assessment: Lessons Learned and Compelling Needs

by Jenna Ogilvie | Jan 18, 2022 | Discussion Paper, Perspectives

The National Academies are responding to the COVID-19 pandemic. Visit our resource center >>     ABSTRACT |  United States health care spending consumes nearly a fifth of the GDP [1]. While, in many respects, the U.S. health care system is enviable and...